Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cebon

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|April 22, 1995
Transient hypoxaemia during neutrophil recovery in febrile patientsK White, J Cebon
Current Opinion in Hematology|May 1, 1994
Measurement and clinical significance of circulating hematopoietic growth factor levelsJ Cebon, J Layton
Lancet (London, England)|May 1, 1997
Clinical promise of tumour immunologyA M Scott, J Cebon
Blood|December 1, 1989
Characterization of the clinical effects after the first dose of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factorG J Lieschke, J Cebon, G Morstyn
Biochemical Society Symposium|January 1, 1989
Haemopoietic growth factor control of normal and neoplastic cellular proliferationA W Burgess, J Cebon, S Smith
Leukemia & Lymphoma|December 24, 1997
Viability and quantification of progenitor cells in venesected blood from patients receiving escalated-dose epirubicin and cyclophosphamide with G-CSF for lymphoma: potential role in further increasing dose-intensityE O'Flaherty, J Cebon, A P Grigg
The Australasian Journal of Dermatology|June 1, 1997
Immunotherapy of melanoma: targeting defined antigensJ Cebon, D MacGregor, A Scott, et al.
Australian and New Zealand Journal of Medicine|August 1, 1985
A 70 year old man with portal hypertensionF J Dudley, J Cebon, H J Ireton
British Journal of Haematology|February 1, 1994
Endogenous haemopoietic growth factors in neutropenia and infectionJ Cebon, J E Layton, D Maher, et al.
The Lancet. Oncology|March 22, 2002
The use of dendritic cells in cancer therapyM Jefford, E Maraskovsky, J Cebon, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|April 22, 1995
Transient hypoxaemia during neutrophil recovery in febrile patientsK White, J Cebon
Current Opinion in Hematology|May 1, 1994
Measurement and clinical significance of circulating hematopoietic growth factor levelsJ Cebon, J Layton
Lancet (London, England)|May 1, 1997
Clinical promise of tumour immunologyA M Scott, J Cebon
Blood|December 1, 1989
Characterization of the clinical effects after the first dose of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factorG J Lieschke, J Cebon, G Morstyn
Biochemical Society Symposium|January 1, 1989
Haemopoietic growth factor control of normal and neoplastic cellular proliferationA W Burgess, J Cebon, S Smith
Leukemia & Lymphoma|December 24, 1997
Viability and quantification of progenitor cells in venesected blood from patients receiving escalated-dose epirubicin and cyclophosphamide with G-CSF for lymphoma: potential role in further increasing dose-intensityE O'Flaherty, J Cebon, A P Grigg
The Australasian Journal of Dermatology|June 1, 1997
Immunotherapy of melanoma: targeting defined antigensJ Cebon, D MacGregor, A Scott, et al.
Australian and New Zealand Journal of Medicine|August 1, 1985
A 70 year old man with portal hypertensionF J Dudley, J Cebon, H J Ireton
British Journal of Haematology|February 1, 1994
Endogenous haemopoietic growth factors in neutropenia and infectionJ Cebon, J E Layton, D Maher, et al.
The Lancet. Oncology|March 22, 2002
The use of dendritic cells in cancer therapyM Jefford, E Maraskovsky, J Cebon, et al.
Pageof 7